BridgeBio Pharma, Inc.

Direct answer

BridgeBio Pharma, Inc. is publicly traded on NASDAQ under the ticker BBIO.

BridgeBio Pharma, Inc. is a pharmaceutical company dedicated to identifying, advancing, and providing medical solutions for various genetic conditions. The firm boasts an extensive portfolio comprising 30 distinct development initiatives, spanning the entire spectrum from initial discovery research to advanced clinical trial phases. Notable candidates within its development pipeline include: AG10 and BBP-265: A...

Can you invest in BridgeBio Pharma, Inc.?

Yes. BridgeBio Pharma, Inc. is publicly traded on NASDAQ under the ticker BBIO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for BridgeBio Pharma, Inc.

Detailed equity research is provided by MarketSnap.